Concorde Asset Management, LLC Twist Bioscience Corp Transaction History
Concorde Asset Management, LLC
- $173 Million
- Q3 2024
A detailed history of Concorde Asset Management, LLC transactions in Twist Bioscience Corp stock. As of the latest transaction made, Concorde Asset Management, LLC holds 10,906 shares of TWST stock, worth $571,147. This represents 0.28% of its overall portfolio holdings.
Number of Shares
10,906
Previous 11,401
4.34%
Holding current value
$571,147
Previous $561,000
12.3%
% of portfolio
0.28%
Previous 0.35%
Shares
5 transactions
Others Institutions Holding TWST
# of Institutions
255Shares Held
66.9MCall Options Held
127KPut Options Held
45.4K-
Artisan Partners Limited Partnership Milwaukee, WI6.02MShares$315 Million0.43% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.62MShares$294 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.42MShares$284 Million0.01% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.36MShares$281 Million2.3% of portfolio
-
Invesco Ltd. Atlanta, GA3.64MShares$191 Million0.03% of portfolio
About Twist Bioscience Corp
- Ticker TWST
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 56,363,500
- Market Cap $2.95B
- Description
- Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...